# Gemini Therapeutics Inc. (GMTX)

Source: https://www.quantisnow.com/company/GMTX
Generated: 2026-11-12T15:18:38.943Z

- Ticker: GMTX
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- Website: geminitherapeutics.com

## About

Gemini Therapeutics, Inc., a clinical stage precision medicine company, engages in developing various therapeutic compounds for treating genetically defined age-related macular degeneration (AMD) and linked ocular disorders. Its lead candidate is GEM103, a recombinant form of the human complement factor H protein that is in a Phase 2a trials in dry AMD patients with a complement factor H protein risk variant. The company was founded in 2015 and is based in Cambridge, Massachusetts.

## Latest GMTX news and filings

- 2024-02-16 01:37 UTC [SEC Form 4] [Franchi Jean M. was granted 36,666 shares (SEC Form 4)](https://www.quantisnow.com/insight/franchi-jean-m-was-granted-36666-shares-sec-form-4-5269280)
- 2024-02-16 01:33 UTC [SEC Form 3] [SEC Form 3 filed by new insider Franchi Jean M.](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-franchi-jean-m-5269277)
- 2024-02-14 21:08 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Gemini Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-gemini-therapeutics-inc-amendment-5263217)
- 2024-02-13 23:51 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Gemini Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-gemini-therapeutics-inc-amendment-5258059)
- 2024-02-09 13:50 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Gemini Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-gemini-therapeutics-inc-amendment-5243999)
- 2024-02-07 13:10 UTC [SEC Form 8-K] [Gemini Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure](https://www.quantisnow.com/insight/gemini-therapeutics-inc-filed-sec-form-8-k-regulation-fd-disclosure-5235922)
- 2024-02-07 12:24 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Gemini Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-gemini-therapeutics-inc-amendment-5235636)
- 2024-01-25 21:38 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Gemini Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-gemini-therapeutics-inc-amendment-5208618)
- 2024-01-25 21:33 UTC [SEC Form 4] [Bitterman Kevin sold $6,934,125 worth of shares (102,500 units at $67.65) (SEC Form 4)](https://www.quantisnow.com/insight/bitterman-kevin-sold-6934125-worth-of-shares-102500-units-at-5208570)
- 2024-01-25 21:31 UTC [SEC Form 4] [Atlas Venture Fund X, L.P. sold $10,147,500 worth of shares (150,000 units at $67.65) (SEC Form 4)](https://www.quantisnow.com/insight/atlas-venture-fund-x-lp-sold-10147500-worth-of-shares-5208556)
- 2024-01-23 22:47 UTC [SEC Form 144] [SEC Form 144 filed by Gemini Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-gemini-therapeutics-inc-5202486)
- 2024-01-23 22:44 UTC [SEC Form 144] [SEC Form 144 filed by Gemini Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-gemini-therapeutics-inc-5202477)
- 2024-01-12 22:12 UTC [SEC Form 4] [Bitterman Kevin sold $1,280,000 worth of shares (20,000 units at $64.00) (SEC Form 4)](https://www.quantisnow.com/insight/bitterman-kevin-sold-1280000-worth-of-shares-20000-units-at-5186373)
- 2024-01-12 22:12 UTC [SEC Form 4] [Atlas Venture Fund X, L.P. sold $3,200,000 worth of shares (50,000 units at $64.00) (SEC Form 4)](https://www.quantisnow.com/insight/atlas-venture-fund-x-lp-sold-3200000-worth-of-shares-5186370)
- 2024-01-11 02:51 UTC [SEC Form 144] [SEC Form 144 filed by Gemini Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-gemini-therapeutics-inc-5182596)
- 2024-01-11 02:44 UTC [SEC Form 144] [SEC Form 144 filed by Gemini Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-gemini-therapeutics-inc-5182593)
- 2024-01-03 21:05 UTC [SEC Form 4] [Quisel John D exercised 2,700 shares at a strike of $1.01 (SEC Form 4)](https://www.quantisnow.com/insight/quisel-john-d-exercised-2700-shares-at-a-strike-of-5164738)
- 2023-12-29 21:15 UTC [SEC Form 4] [Bryce Joanne exercised 3,000 shares at a strike of $9.86, increasing direct ownership by 120% to 5,500 units (SEC Form 4)](https://www.quantisnow.com/insight/bryce-joanne-exercised-3000-shares-at-a-strike-of-986-5158996)
- 2023-12-20 23:28 UTC [SEC Form 4] [Orbimed Advisors Llc exercised 1,724 shares at a strike of $38.00 and sold $102,130 worth of shares (1,724 units at $59.24) (SEC Form 4)](https://www.quantisnow.com/insight/orbimed-advisors-llc-exercised-1724-shares-at-a-strike-of-5149659)
- 2023-12-20 23:16 UTC [SEC Form 4] [Ashiya Mona sold $102,130 worth of shares (1,724 units at $59.24) and exercised 1,724 shares at a strike of $38.00 (SEC Form 4)](https://www.quantisnow.com/insight/ashiya-mona-sold-102130-worth-of-shares-1724-units-at-5149656)
- 2023-12-15 23:18 UTC [SEC Form 144] [SEC Form 144/A filed by Gemini Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-144a-filed-by-gemini-therapeutics-inc-amendment-5141460)
- 2023-12-15 23:15 UTC [SEC Form 144] [SEC Form 144/A filed by Gemini Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-144a-filed-by-gemini-therapeutics-inc-amendment-5141455)
- 2023-12-15 23:11 UTC [SEC Form 144] [SEC Form 144/A filed by Gemini Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-144a-filed-by-gemini-therapeutics-inc-amendment-5141450)
- 2023-12-15 23:09 UTC [SEC Form 4] [Ashiya Mona sold $24,584,100 worth of shares (433,200 units at $56.75) (SEC Form 4)](https://www.quantisnow.com/insight/ashiya-mona-sold-24584100-worth-of-shares-433200-units-at-5141443)
- 2023-12-15 23:04 UTC [SEC Form 4] [Orbimed Advisors Llc sold $24,584,100 worth of shares (433,200 units at $56.75) (SEC Form 4)](https://www.quantisnow.com/insight/orbimed-advisors-llc-sold-24584100-worth-of-shares-433200-units-5141429)
- 2023-12-15 21:48 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Gemini Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-gemini-therapeutics-inc-amendment-5141102)
- 2023-12-15 01:14 UTC [SEC Form 4] [Bitterman Kevin sold $4,673,759 worth of shares (76,064 units at $61.45) (SEC Form 4)](https://www.quantisnow.com/insight/bitterman-kevin-sold-4673759-worth-of-shares-76064-units-at-5139248)
- 2023-12-15 01:13 UTC [SEC Form 4] [Atlas Venture Fund X, L.P. sold $11,684,586 worth of shares (190,163 units at $61.45) (SEC Form 4)](https://www.quantisnow.com/insight/atlas-venture-fund-x-lp-sold-11684586-worth-of-shares-5139247)
- 2023-12-14 22:44 UTC [SEC Form 4] [Orbimed Advisors Llc sold $7,902,266 worth of shares (134,200 units at $58.88) (SEC Form 4)](https://www.quantisnow.com/insight/orbimed-advisors-llc-sold-7902266-worth-of-shares-134200-units-5139076)
- 2023-12-14 22:40 UTC [SEC Form 4] [Ashiya Mona sold $7,902,266 worth of shares (134,200 units at $58.88) (SEC Form 4)](https://www.quantisnow.com/insight/ashiya-mona-sold-7902266-worth-of-shares-134200-units-at-5139061)
- 2023-12-14 21:15 UTC [SEC Form 4] [Bryce Joanne exercised 2,500 shares at a strike of $2.65 and sold $163,062 worth of shares (2,500 units at $65.22) (SEC Form 4)](https://www.quantisnow.com/insight/bryce-joanne-exercised-2500-shares-at-a-strike-of-265-5138471)
- 2023-12-14 21:15 UTC [SEC Form 4] [White William Richard exercised 33,511 shares at a strike of $6.08 and sold $2,118,239 worth of shares (33,511 units at $63.21) (SEC Form 4)](https://www.quantisnow.com/insight/white-william-richard-exercised-33511-shares-at-a-strike-of-5138468)
- 2023-12-12 23:03 UTC [SEC Form 144] [SEC Form 144 filed by Gemini Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-gemini-therapeutics-inc-5133779)
- 2023-12-12 23:00 UTC [SEC Form 144] [SEC Form 144 filed by Gemini Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-gemini-therapeutics-inc-5133772)
- 2023-12-12 22:58 UTC [SEC Form 144] [SEC Form 144 filed by Gemini Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-gemini-therapeutics-inc-5133767)
- 2023-12-12 22:53 UTC [SEC Form 144] [SEC Form 144 filed by Gemini Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-gemini-therapeutics-inc-5133745)
- 2023-12-12 22:42 UTC [SEC Form 144] [SEC Form 144 filed by Gemini Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-gemini-therapeutics-inc-5133693)
- 2023-12-12 21:19 UTC [SEC Form 144] [SEC Form 144 filed by Gemini Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-gemini-therapeutics-inc-5133155)
- 2023-12-12 01:35 UTC [SEC Form 8-K] [Gemini Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/gemini-therapeutics-inc-filed-sec-form-8-k-regulation-fd-disclosure-5131397)
- 2023-12-11 17:11 UTC [SEC Form 8-K] [Gemini Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/gemini-therapeutics-inc-filed-sec-form-8-k-regulation-fd-disclosure-5129788)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/GMTX
- Earnings history: https://www.quantisnow.com/earnings/GMTX
- Dividend history: https://www.quantisnow.com/dividends/GMTX
- Insider transactions: https://www.quantisnow.com/insiders/GMTX
- Options chain: https://www.quantisnow.com/options/GMTX
- SEC 8-K filings only: https://www.quantisnow.com/company/GMTX/8-k
- RSS and alerts for GMTX: https://www.quantisnow.com/docs/rss-feeds.md